
major surgery classic hemophilia using fraction i.  experience 
twelve operations review literature. 
   therapeutic regimen provides hemostasis 
hemophiliacs major surgery without requiring 
laboratory control established 
factor viii concentrate.  effectiveness regimen 
fraction therapy evaluated major surgery 
6 severely deficient 4 moderately deficient hemophiliacs. 
analysis clinical results made, combining 
12 operations series 116 major 
operative procedures hemophiliacs recorded 
english literature, fraction sole 
major source factor viii therapy.  dental nondental 
surgery analyzed separately, 
special problem blood cysts.  although over-all 
mortality rate following major surgery hemophiliacs 
presently 5 10% using factor viii concentrates, 
problems still remain.  include continued high 
incidence abnormal postoperative hemorrhage, 
variation factor viii potency different lots fraction 
i, late development serum hepatitis, hemolytic 
anemia due contaminating isoantibodies 
high cost adequate amounts product.  efficient 
methods preparing purer potent factor 
viii concentrates eliminate difficulties. 
